Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Schweizerische Medizinische Wochenschrift
|
October 30, 1998
Myocardial dysfunction in sepsis: clinical and experimental investigations
A F Suffredini
Critical Care Medicine
|
July 1, 1994
Current prospects for the treatment of clinical sepsis
A F Suffredini
Journal of Endotoxin Research
|
December 26, 2001
Human models of innate immunity: local and systemic inflammatory responses
C Fiuza, A F Suffredini
Clinical Pharmacology and Therapeutics
|
September 20, 2014
Human endotoxin administration as an experimental model in drug development
A F Suffredini, R J Noveck
Neuroimmunomodulation
|
September 1, 1995
Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects
A Catania, A F Suffredini, J M Lipton
The Journal of Infectious Diseases
|
April 7, 1999
Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin
A F Suffredini, H D Hochstein, F G McMahon
Immunobiology
|
April 1, 1993
Response of man to endotoxin
G D Martich, A J Boujoukos, A F Suffredini
The New England Journal of Medicine
|
May 4, 1989
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
A F Suffredini, P C Harpel, J E Parrillo
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1994
Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity
L Yan, R W Vandivier, A F Suffredini, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 1, 1993
Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration
A J Boujoukos, G D Martich, E Supinski, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Schweizerische Medizinische Wochenschrift
|
October 30, 1998
Myocardial dysfunction in sepsis: clinical and experimental investigations
A F Suffredini
Critical Care Medicine
|
July 1, 1994
Current prospects for the treatment of clinical sepsis
A F Suffredini
Journal of Endotoxin Research
|
December 26, 2001
Human models of innate immunity: local and systemic inflammatory responses
C Fiuza, A F Suffredini
Clinical Pharmacology and Therapeutics
|
September 20, 2014
Human endotoxin administration as an experimental model in drug development
A F Suffredini, R J Noveck
Neuroimmunomodulation
|
September 1, 1995
Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects
A Catania, A F Suffredini, J M Lipton
The Journal of Infectious Diseases
|
April 7, 1999
Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin
A F Suffredini, H D Hochstein, F G McMahon
Immunobiology
|
April 1, 1993
Response of man to endotoxin
G D Martich, A J Boujoukos, A F Suffredini
The New England Journal of Medicine
|
May 4, 1989
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
A F Suffredini, P C Harpel, J E Parrillo
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1994
Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity
L Yan, R W Vandivier, A F Suffredini, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 1, 1993
Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration
A J Boujoukos, G D Martich, E Supinski, et al.
Page
of 6